Cedars Sinai Intellectual Property Co, Ten Percent Owner at Prometheus Biosciences, holds 4.00M shares in Prometheus Biosciences (Ticker: RXDX). Most recently, Cedars Sinai Intellectual Property Co Sold $865,000 shares of Prometheus Biosciences on Mar 08, 2023 for an estimated value of 99.12M.